Anavex Life Sciences Board of Directors Appoints Former Senior Vice President of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer
Go back to Anavex Life Sciences Board of Directors Appoints Former Senior Vice President of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer| Anavex Life Sciences Corp. (NASDAQ: AVXL) | Delayed: 2.54 -0.19 (6.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.73 | 52 Week High | $8.30 | |||
| Open | $2.73 | 52 Week Low | $2.43 | |||
| Day High | $2.80 | P/E | N/A | |||
| Day Low | $2.53 | EPS | $-0.22 | |||
| Volume | 1,145,638 | |||||
